Demand of Fragment-based Drug Discovery Market in Global Industry : Overview, Size, Share, Trends, Analysis and Research 2017

ResearchMoz presents professional and in-depth study of "Fragment-based Drug Discovery Market (Service Component: Fragment screening and Fragment Optimization; End-user: Biopharmaceutical Companies, CROs and, Academic and Research Institutions) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023".

The increasing search for new drugs to treat complicated medical problems has led to a surge in the global fragment-based drug discovery market. Furthermore, the growth of the global fragment-based drug discovery market has also led to dominance of biopharmaceutical companies, as the market requires a system for identification of lead compounds in the process of drug discovery.

The report published by Transparency Market Research on the global fragment-based drug discovery market gives a comprehensive overview of the important dynamics and trends. The report assesses the threat from new entrants, threat of substitute products or services, bargaining power of customers, bargaining power of suppliers, and the intensity of competitive rivalry with the help of a Porter’s five forces analysis. Furthermore, it also evaluates the strengths, weaknesses, opportunities, and threats of the market with the help of a SWOT analysis. The report gives a clear understanding of the competitive landscape and segmentation of the market and an overview of the global fragment-based drug discovery market to enable its readers to make well-informed business decisions.

Overview of Global Fragment-Based Drug Discovery Market

The drivers for the global fragment-based drug discovery market are its time-saving attributes and quick access to biophysical fragment screening techniques. Fragment-based drug discovery has become a method of designing unique molecules. This technique uses smaller ‘fragments or ligands’, which have lower molecular weights. The main restraint on the global fragment-based drug discovery market is the weak potency of a few compounds that are derived from fragment screening. The other conspicuous restraint on this market is the need for special ‘fragment libraries’ for conducting research.

Get PDF for more Professional and Technical insights @ http://www.researchmoz.us/enquiry.php?type=S&repid=444862

The global fragment-based drug discovery market has been segmented into fragment screening and fragment optimization. The fragment screening segment is further sub-segmented into biophysical techniques and non-biophysical techniques. Biophysical techniques include isothermal titration calorimetry (ITC), nuclear magnetic resonance (NMR) spectroscopy, fluorescence polarization (FP), differential scanning fluorimetry (DSF), surface plasmon resonance, X-ray crystallography, assay (thermal shift), biolayer interferometry, capillary electrophoresis, mass spectrometry, and others (biochemical assays). The end-use applications encouraging the growth of this market are CROs, biopharmaceutical companies, and academic and research institutions. Geographically, the global fragment-based drug discovery market is divided into regions such as North America, Asia Pacific, Europe, Latin America, and Rest of the World.

North America dominated the global fragment-based drug discovery market due to growing awareness about this sector and the high level of its adoption by pharmaceutical companies. However, in the coming years, the Asia Pacific fragment-based drug discovery market will witness phenomenal growth due to the growing number of research and development activities.

Companies Mentioned in the Global Fragment-Based Drug Discovery Market Report

The important players in the global fragment-based drug discovery market are Astex Pharmaceuticals, Beactica AB, Structure Based Design, Inc., Alveus Pharmaceuticals Pvt. Ltd., Emerald BioStructures, Inc., Evotec AG, Crown Bioscience, Inc., Kinetic Discovery Limited, Sprint Bioscience, Proteros Fragments GmbH, Charles River Laboratories International, Inc., and Sygnature Discovery.

The global fragment-based drug discovery market has been segmented as follows:

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=444862

Fragment-Based Drug Discovery Market, by Services Component

    Fragment Screening
    Biophysical Techniques
    Nuclear Magnetic Resonance (NMR) Spectroscopy
    Differential scanning Fluorimetry (DSF) Assay (Thermal Shift)
    Fluorescence Polarization (FP)
    Isothermal Titration Calorimetry (ITC)
    X-ray Crystallography
    Surface Plasmon Resonance
    Biolayer Interferometry
    Mass Spectrometry
    Capillary Electrophoresis
    Others (Biochemical Assays)
    Non-biophysical Techniques
    Fragment Optimization

For More Information Kindly Contact:

ResearchMoz
Mr. Nachiket Ghumare,
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow me on Blogger at: http://researchreportlife.blogspot.in//

Comments

Popular posts from this blog

Competitive Dynamics : Global Polyethylene Furanoate (PEF) Market Insights, Forecast 2018 to 2025

New Era of Concrete Pumps Market – “Global Market” is growing in Huge Demand in 2019

Orthokeratology Market : Technological Advancements, Evolving Industry Trends and Insights 2019 – 2028